| U.S. to promote use of opioid alternatives to treat addiction | | | (Reuters) - The U.S. Food and Drug Administration plans to encourage widespread use among opioid addicts of less harmful opioid drugs such as methadone and buprenorphine, a radical shift in policy that could draw opposition from those in the addiction field who believe abstinence is the only effective treatment. |
| |
| High cholesterol levels among U.S. adults declining: CDC report | | | NEW YORK (Reuters) - The prevalence of U.S. adults with high cholesterol declined significantly between 1999-2000 and 2015-2016, achieving a long-term public health goal, according to data released on Thursday by the Centers for Disease Control and Prevention's National Center for Health Statistics. |
| |
| Opioid drugmaker Purdue Pharma faces U.S. investigation | | | (Reuters) - Purdue Pharma LP confirmed on Wednesday that it has become the subject of a U.S. investigation related to its painkiller OxyContin as the drugmaker battles a series lawsuits seeking to hold it responsible for its role in the nation's opioid epidemic. |
| |
| FDA declines to approve PTC's Duchenne drug | | | (Reuters) - The U.S. Food and Drug Administration has declined to approve PTC Therapeutics Inc's experimental drug to treat Duchenne muscular dystrophy, saying an additional clinical trial would be needed to prove the drug works. |
| |
| Conjoined twins posed ethical dilemma for Massachusetts hospital | | | BOSTON (Reuters) - Doctors at the MassGeneral Hospital for Children faced an ethical challenge when a pair of conjoined twins born in Africa arrived last year seeking surgery that could save only one of them, according to a medical journal article due out Thursday. |
| |
| | |
